Riverside University Health System Uses VigiLanz for NICU Antimicrobial Stewardship

Customer Profile 

Riverside University Health System Medical Center (RUHS), a 439-bed facility in Moreno Valley, California, is committed to delivering exceptional care—and its quality performance reflects that commitment. Recognized by The Joint Commission as a top performer on key quality measures, RUHS has received awards from the American Heart Association/American Stroke Association. It is also recognized as a Baby Friendly Hospital by the World Health Organization and the United Nations Children’s Fund.

Challenge

As part of its commitment to providing optimal patient care, RUHS participates in the California Perinatal Quality Care Collaborative, a statewide network of California’s neonatal intensive care units (NICUs) and high risk infant follow-up clinics. In 2016, the collaborative launched an antibiotic stewardship (ASP) initiative with 28 NICUs, including RUHS.

At that time, RUHS had an antimicrobial stewardship program (ASP) for all patients, but it did not have a program that was focused solely on pediatric and NICU patients. “As we looked more closely at the younger patient population, we realized there was room for improvement in this area,” said Nikita Patel, Assistant Director of Pharmacy–Clinical Programs & Quality Improvement at RUHS.

She noted that, while there are established clinical practice guidelines for neonatal early onset sepsis management, they can contribute to higher antibiotic use—sometimes unnecessarily.

“If a baby has an active infection the first two to three days of life, the mortality outcomes are staggering and antibiotic use can be life-saving,” said Patel. “But unnecessary antibiotic use can disrupt a baby’s gut microbiome and impact their long-term immune response. This puts them at a higher risk of developing chronic diseases like asthma, and can lead to antibiotic resistance.”

Solution

RUHS turned to VigiLanz to support its efforts to optimize antibiotic use among pediatric and NICU patients. The clinical surveillance solution—which continuously gathers information from the medical center’s EMR and other sources, analyzes that data in real time, and provides meaningful insights to healthcare providers—enables pharmacists to view robust antimicrobial utilization reports. “The reports help us continuously monitor antimicrobial use and assess prescribing trends,” said Patel.

VigiLanz also provides relevant healthcare providers with real-time alerts that promote ASP in the NICU. These alerts include:

  • 48-hour antibiotic timeouts that enable NICU pharmacists to review information and recent lab results on relevant patients.
  • Positive lab results, so that pharmacists more quickly review critical labs and make appropriate medication change recommendations or antibiotic de-escalation.
  • Pharmacokinetic monitoring alerts, so that pharmacists can immediately make recommendations regarding dosage changes.
“I can’t emphasize enough how valuable VigiLanz is for us. It helps drive timely and important patient care interventions and improves our efficiency and documentation.” – Nikita Patel, Assistant Director of Pharmacy – Clinical Programs & Quality Improvement, RUHS

Outcomes

The new approach to ASP at RUHS has had a significant positive effect on patient care, said Patel. “I can’t emphasize enough how valuable VigiLanz is for us,” she said. “It helps drive timely and important patient care interventions and improves our efficiency and documentation.”

Two noteworthy outcomes of the new approach include:

  • A 37% decrease in NICU antibiotic utilization between March 2017 and March 2018. Importantly, that 37% drop has also been sustained since 2018.
  • More than 90% compliance with 48-hour antibiotic timeouts for all patients admitted to the NICU and initiated on antimicrobials.

VigiLanz also saves pharmacists time, which also benefits patient care, said Patel. “We no longer have to manually review patient lists and data every day,” she explained. “VigiLanz automatically sorts relevant data for us and alerts us when there’s a potential problem or when there’s something new to review. That helps us intervene more quickly and spend more time on other patient care improvement initiatives.”

 

To learn more about how VigiLanz helps hospitals improve their patient safety and clinical surveillance, visit https://vigilanzcorp.com/ today.

Freeman Health System Uses VigiLanz to Enhance MRSA Screening, Reduce Vancomycin Use

Customer Profile

Freeman Health System, a 485-bed, three-hospital system in Joplin, Missouri, serves an area of 450,000 people across Missouri, Arkansas, Kansas, and Oklahoma. It is the #1 hospital in Southwest Missouri and the #4 hospital in Missouri, according to U.S. News & World Report.

Challenge

Hospitals across the country are fighting to combat antibiotic overuse, resistance, and unwanted side effects, but many are struggling to implement new and effective workflows that help meet these goals. Much of the challenge boils down to speed and efficiency—hospitals need to identify antibiotic overuse more quickly, and intervene sooner when it does occur.

Freeman Health System is no exception to the challenges associated with antimicrobial stewardship (ASP), and it was looking for a way to improve its ASP processes, particularly related to vancomycin use among patients with pneumonia.

“Data shows that 98 percent of the time, a negative MRSA screen for a patient with pneumonia means that a patient does not have MRSA-pneumonia, and their empiric vancomycin therapy can safely be discontinued,” said Adrienne Carey, PharmD, BCPS, Clinical Pharmacist and Data Mining Program Manager at Freeman Health System. “We wanted to streamline our MRSA screening process so that we could more quickly identify if a MRSA screen is negative, and therefore, discontinue vancomycin use sooner.”

Solution

Freeman Health System’s antibiotic stewardship team had already changed the health system’s pneumonia pathway orders to ensure all patients who came into the ER automatically received a nasal screen for MRSA.

“Our pharmacy department was tasked with educating physicians about the change and with contacting them with the results,” said Carey. “The goal was to de-escalate patients’ antibiotics more quickly.”

The problem was that results were not always communicated quickly to pharmacists, so there was sometimes a delay in identifying patients whose vancomycin therapy could be discontinued.

Freeman Health System turned to VigiLanz to help, working with the VigiLanz clinical support team to create a negative MRSA screen rule within the system. Now, whenever a patient prescribed vancomycin has a negative MRSA screen and no other cultures are positive for MRSA, the pharmacy team and infectious disease physician receive an alert in real time.

“Before implementing the VigiLanz rule, we had to manually run reports through our health information system to view all patients on vancomycin, then check each patient’s microbiology results to see if they had been screened for MRSA,” said Carey. “That took a lot of time.”

Now, pharmacists and physicians can more quickly discontinue vancomycin use and switch to an alternate antibiotic when appropriate, she explained. “We are not leaving our patients on vancomycin any longer than necessary.”


Adrienne Carey, PharmD, BCPS describes real-time alerts helping pharmacists

Outcomes 

In the first six months since November 2018, when the new workflow was implemented, Freeman Health System’s pharmacists worked with physicians to discontinue vancomycin therapy in 70 patients.

Other key benefits of the new approach include:

  • Time savings for pharmacists
  • Time savings for nurses by reducing doses and drawing fewer labs
  • Monetary savings by reducing unneeded antibiotics
  • Reduced risk of infection through an IV route since IV lines are discontinued sooner due to de-escalation
  • Fewer medication side effects
  • Less chance for antibiotic resistance
  • Improved patient satisfaction due to fewer medications being administered
  • Shorter lengths of stay

“Building this rule and receiving immediate alerts from VigiLanz is helping us better identify all patients who qualify to have their therapy de-escalated and do so in a timely fashion,” said Carey. “We have also seen a trend toward less vancomycin usage overall.”

Related Resource:

Capital Region Medical Center Uses VigiLanz to Prevent Bedbug Infestations

Hospitals across the country are using VigiLanz to complement patient care in many ways. Top uses include pharmacy surveillance, infection prevention, antimicrobial stewardship, and opioid stewardship. But VigiLanz is also completely customizable, so the most innovative and forward-thinking hospitals are using it to create new and unique rules and interventions that lead to optimal patient care. Capital Region Medical Center is one of them.  

Customer Profile

Capital Region Medical Center (CRMC), a 100-bed facility in Jefferson City, Missouri, is committed to providing superior patient care, and its safety and quality performance reflects that mission. The hospital, which provides the full spectrum of patient services, is the only one in the area to have received the Missouri Quality Award twice. The Joint Commission has also recognized CRMC as a top performer on quality metrics.

Challenge

An important aspect of providing high quality patient care is fostering a bedbug-free environment. But all hospitals—even those like CRMC that adhere to the highest cleanliness standards—can struggle to keep these pests at bay.

That’s because for most hospitals, bedbugs represent an external challenge, rather than an internal one. Many patients unknowingly bring bedbugs into facilities from the outside, and once the pests gain admittance, they quickly infiltrate the system.

Addressing these infestations can cost hospitals a significant amount of money. A March 2019 study of a 937-bed hospital in Cleveland, Ohio, found that during a one-year period, the hospital had 180 bedbug infestations. Costs were between $125 and $1,050 per infestation, with total costs for the year totaling $22,844 for the ED and $55,915 for the hospital.

While bedbug bites are generally not considered a health hazard, the itchy, red welts can lead to infections if patients scratch them. In hospitals, where there is a higher likelihood of catching MRSA, this is particularly problematic. Bedbug infestations also drive down patient satisfaction, which can lead to lower revenue for hospitals participating in value-based payment models.

Solution

In January 2017, CRMC implemented VigiLanz to support its pharmacy surveillance and infection prevention initiatives. Immediately, the value it provided became clear—and the healthcare providers’ use of the clinical surveillance platform has continually led to higher quality care and reduced costs (see sidebar).

But as CRMC was exploring the VigiLanz platform that January, they recognized there was much more they could be doing with it. “Since the software is completely customizable, we knew we could create new rules and alerts based on our needs and initiatives,” said Valerie Lyon, RN, AA, AS, BSN, CIC, Infection Preventionist at CRMC. “That led me to begin considering how we could use it to curb bedbugs.”

Less than one month after implementing VigiLanz, Lyon’s curiosity and innovative idea resulted in the rollout of a new protocol around bedbug-sightings at CRMC.

 

CRMC’s Bedbug-Sighting Process

 

“The whole process was built around VigiLanz’s ability to automatically identify that lab result as soon as it is available, and immediately send an alert and email notification,” said Lyon.

CRMC is also using VigiLanz to address environmental bedbug sightings (when a bedbug is spotted but can’t be tied back to a specific patient). In this case, healthcare providers enter the bedbug information into the EMR as a lab for a “dummy patient.” If the lab determines that it is in fact a bedbug, VigiLanz automatically issues alerts and sends emails to the appropriate parties.

Outcomes

CRMC’s bedbug identification process is helping to prevent infestations, control costs, and increase efficiency, said Lyon. Since healthcare providers know much more quickly if there has been a potential bedbug sighting, and they are alerted as soon as a bedbug is confirmed, it’s much easier to limit the movement of these patients through the facility.

This reduces the number of rooms that need pest control treatment, said Lyon, noting that prior to implementing the new process, CRMC regularly performed pest control treatments in multiple rooms and procedural areas.

Since implementing VigiLanz in 2017, the average number of bedbug alerts issued annually has been 14, and CRMC has experienced zero infestations.

“The rules we created enable us to be proactive rather than reactive,” said Lyon. “The real-time alerts help us respond the same day we receive a bed bug alert, which mitigates any risk of a bedbug infestation.”

 

To learn more about how VigiLanz helps hospitals improve their patient safety and clinical surveillance, request a demo today.

VigiLanz Improves Efficiency, Patient Care at Riverside University Health System

Andy Williams, PharmD, BCPP, BCGP, Senior Clinical Pharmacist at Riverside University Health System, discusses how VigiLanz improves patient care.

“I’ve seen VigiLanz make some very strong, important interventions, especially in the realm of our pharmacokinetic monitoring,” says Williams, adding that VigiLanz serves as a second set of eyes for pharmacists.

Watch this short video to learn more about how Williams and his team are using VigiLanz to improve patient care.

 


Transcript:

I think the biggest benefit that VigiLanz provides for patient care is that it helps us work more efficiently, so we’re able to quickly get the information that we need, so that we can spend more time out on treatment team rounds or out directly interacting with patients on the unit  conducting our pharmacist-led patient education groups. It helps us to take care of any reports or lab monitoring we need to do quickly and efficiently, so that we’re able to then realign our time on something else that could help strengthen patient care.

Since we are a psychiatric hospital, we may have a little bit unique methods in which we use VigiLanz. We use VigiLanz largely for our reports, so it’s able to help us with conducting our quality assurance measures. We’re able to run reports on which patients have received long-acting injectable anti-psychotics each quarter, and then cross compare that with their readmission rates. We’re able to use it to run our Joint Commission Hospital-Based Inpatient Psychiatric Services measures to see patients that are on two or more anti-psychotics. We’re able to use it to run whether or not they have appropriate labs, so if they have their lipid panels or their A1Cs for the patients that are receiving second generation antipsychotics, as well as for pharmacokinetic monitoring of Lithium or valproic acid sodium. 

I’ve seen VigiLanz make some very strong, important interventions, especially in the realm of our pharmacokinetic monitoring. Many of our patients are receiving Lithium, which is a narrow therapeutic index drug, and with that, it has the potential for many drug interactions. It could be very easy for one of our pharmacists to overlook a lab or not see an out-of-range lab. VigiLanz is able to provide that safety net and that second look of eyes to alert us in real time if something is out of range so that we can act quickly, without leaving the patient exposed to a higher level or risk them receiving another dose when that really isn’t appropriate.”

VigiLanz Provides Efficiency Improvements, Life-Saving Interventions at Freeman Health System

Adrienne Carey, PharmD, BCPS, Clinical Pharmacist at Freeman Health System, discusses how VigiLanz improves efficiency and helps saves patients’ lives.

“VigiLanz impacts our efficiency because it shows us what we need to intervene on in real time,” says Carey. “We use our health information system also, but we are pretty much living in the VigiLanz system because it’s real time.”

Watch this short video to learn more about how Carey and her team are using VigiLanz to improve patient care.

 

VigiLanz impacts our efficiency because it shows us what we need to intervene on in real time. So we use, especially our clinical pharmacists on the floor, we live in the VigiLanz software. We use our health information system also, but we are pretty much living in the VigiLanz system because it’s real time. We use it for our medication reconciliation program, so our technicians use it to document all the information that they gather when compiling the patient’s home medication list. We also use it for our clinical pharmacists and our staff pharmacists throughout our system to document all of our activities to help us identify patients that might need some type of intervention from a pharmacist, whether it’s dosing or looking at their IV status or whether we can switch their medications from IV to PO. We look at their antibiotic usage to make sure that we’re covering their bugs appropriately.

We have seen VigiLanz help us identify life-saving interventions for our pharmacy department. For example, we have a rule to help us identify those that are on anticoagulants that have been discontinued or put on hold. So typically when you are on anticoagulants, that’s not something that’s put on hold and then stopped indefinitely; that’s usually something that’s temporarily put on hold and then we really need to resume it after your procedure or after whatever surgery we’re doing or test we’re doing is done. So it has helped us identify those people who it’s been put on hold but somehow it got missed putting back on. Without the anticoagulation, we run the risk of heart attacks, and strokes, and things like that, so the rules that help us find those patients who were on it but for some reason are no longer on it have been very important.

My favorite part of working with VigiLanz has honestly been the customer support. So we have a person on the VigiLanz side on the customer support team that I can submit a ticket to at any moment and they are experts and they are wonderful at getting back to me very quickly and helping me work through whatever issue it is. I’m kind of a do-it-yourself person, so I usually try to create the rules or fix things that I want for our system, but sometimes I come to a roadblock and I usually submit a ticket and the pharmacist on their end has been absolutely wonderful to work with. That’s not something I’ve ever had with any software program I’ve used before.

VigiLanz Helps Pharmacists ‘Work Smarter, Not Harder’ at Antelope Valley Hospital

Jill Bennett, PharmD, BCPS, Clinical Coordinator/Residency Program Director at Antelope Valley Hospital, discusses how VigiLanz has transformed work flows, and is helping staff members work smarter, not harder.

“Certainly the information that you put in more than represents what you can get out of it and the benefit it can add,” she says. “You can get to so much more than you can utilizing manual reporting.”

Watch this short video to learn more about how Bennett and her team are using VigiLanz to improve patient care.

Transcribed video:

On a day to day basis, VigiLanz really drives our work. It’s changed the way we work. We work smarter, not harder, and we’ve been able to really increase what we’re looking at. So, initially what we had to do manually by generating reports and looking at things like certain medications that were given intravenously that could be changed to oral therapy, we instead were able to have it filter through and look at whether or not the patient was on other oral medications, maybe was eating, those types of things that would let us get in tune to the changes that we could make more quickly.

It really drives our work flow. We have the alerts, that’s part of it. Another piece, is certainly our antimicrobial stewardship work. We utilize the antimicrobial stewardship list, and it’s really nice to be able to focus in on which patients need to be seen that are stewardship patients and then actually to be able to check them off and note when we’ve done the follow-up or when we’ve made the needed interventions. So things like drug-bug mismatches, being able to de-escalate therapy when we have those final culture results in, things like that.

I’ve been a real proponent of VigiLanz. I mean I always feel very comfortable in recommending it to other healthcare systems and I feel really lucky that we have this available to us because there certainly are a lot of people that want it and have not been able to justify it in the right way maybe to their administration.

Certainly the information that you put in more than represents what you can get out of it and the benefit it can add. You can get to so much more than you can utilizing manual reporting. So you do work smarter, you can get too many more things, and therefore you use your resources more wisely. It’s been really beneficial to us.

Freeman Health System Uses VigiLanz to Improve Patient Safety While Cutting Costs

Customer Profile

Freeman Health System, a 485-bed, three-hospital system in Joplin, Missouri, serves 450,000 people across Missouri, Arkansas, Kansas, and Oklahoma. It is the #1 hospital in Southwest Missouri and the #4 hospital in Missouri, according to U.S. News & World Report.

Challenge

Medication reconciliation, the process of creating an accurate list of a patient’s medications—including drug name, dosage, frequency, and route—is critical to reducing adverse events and ensuring patient safety.

Yet it can be a cumbersome and time-consuming undertaking, particularly when nurses are already overburdened. Medication reconciliation is also challenging because patients’ medications change frequently and patients often don’t maintain accurate lists.

“While it’s extremely important to quickly and accurately capture a patient’s medication information, traditional approaches that rely primarily on nurses and EMRs make this very difficult,” said Adrienne Carey, PharmD, BCPS, Clinical Pharmacist and Data Mining Program Manager at Freeman Health System. “We knew there had to be a better way.”

Medication non-adherence exacts a heavy toll, both on patients and the broader healthcare industry. According to a review in the Annals of Internal Medicine, 20 to 30 percent of medication prescriptions are never filled, and approximately 50 percent of medications for chronic disease are not taken as prescribed. Each year, this lack of medication adherence is estimated to cause 125,000 deaths and at least 10 percent of hospitalizations, costing the American healthcare system $100-$289 billion.

Solution

One of the first changes Freeman Health System made was related to staffing. Rather than relying solely on nurses for medication reconciliation, it gradually added medication reconciliation technicians (MRTs) to its team. It now has nearly a dozen MRTs working in the emergency room and other departments. “We started them on the cardiology floor as a pilot and their ability to ease the burden on nurses was so clear that we quickly hired more,” said Carey.

The MRTs meet with patients to go over at-home medication information. Then, they verify that information using another source such as the patient’s doctor or pharmacy, and document it in the EMR. “The MRTs are usually able to meet with patients more quickly than nurses can,” said Carey. “That means faster identification of at-home medications, and smarter medication decision making in the hospital.”

Freeman Health System also uses VigiLanz to support and streamline its medication reconciliation efforts. The pharmacy department worked with the VigiLanz clinical support team to create new rules in the clinical surveillance platform to identify patients needing medication reconciliation. When patients are admitted to the ER or to floors with MRTs, MRTs receive an alert to conduct a reconciliation. “After determining what our organization needed, the VigiLanz clinical support team helped us create rules that make the process much more seamless,” said Carey, noting that the rules took effect in June 2018.

Once the reconciliation is complete, a pharmacy team member reviews it, contacts the physician if there are any problems or errors, and documents the information and/or intervention in VigiLanz. Freeman Health System also uses VigiLanz to create an audit trail of who has made changes. Carey noted that the new workflow is a significant improvement over relying on the EMR, where information is not easily retrievable. “While clinicians can pull up a patient’s record and read the history in the EMR, there is no discrete data to track information such as which medications have changed or what problems nurses have already addressed,” said Carey. “We also use VigiLanz to customize intervention categories so pharmacists can better track the prevention of potential major and minor adverse drug events.”

Adrienne Carey, PharmD, BCPS explains how VigiLanz provides efficiency improvements to Freeman Health

Outcomes

Since adopting the new approach, Freeman Health System has completed an average of 1,400 medication reconciliations monthly. That has prevented nearly 30 potential major adverse drug events and  more than 11,000 potential minor adverse events over a one-year period. The health system estimates that it has realized $4.7 million in potential savings from major and minor medication error prevention since July 2018.

“It’s had a huge impact,” said Carey. “We end up making a change to almost every med list that we touch. Those are things that we might have missed if we didn’t have this new system in place.”

In addition to improving care quality and avoiding adverse drug events, VigiLanz’s clinical surveillance platform has trickle-down benefits. “Their data-tracking capabilities help us better recognize our MRTs’ invaluable contributions,” she said. “It helped us make the case for expanding these staff to reach all patients in our facility.”

In addition to using VigiLanz to help avoid adverse drug events and make smarter medication decisions, Freeman Health System uses its clinical surveillance software to flag potential IV to PO conversion opportunities and identify inappropriate medication levels and duration. Overall, the health system estimates that VigiLanz enables it to avoid over $700,000 in monthly costs.

Medication Reconciliation Monthly Totals

Related Resource:

How Houston Methodist is Making Smarter Clinical Decisions, Faster

Healthcare systems across the country are equipping their healthcare providers with more patient data than ever before. While this represents significant progress, it can be difficult for physicians and other providers to turn that data into actionable information. In other words, they often lack the time and resources to sift through all of that data to gather the most meaningful insights that can be applied at the point of care.

Note: Want to earn continuing education credits for watching this presentation? Register for the HIMSS20 digital version here: Making Smarter Clinical Decisions, Faster.

Houston Methodist has found a solution that is leading to higher care quality and reduced costs. The health system is using a tool to provide real-time data (including cost data, as appropriate), related to patients’ medications, labs, and radiology studies—directly within providers’ clinical workflow. The tool also enables access to the state’s prescription monitoring program reports within the clinical workflow. And, it sends context-specific alerts to providers based on EMR, PMP, and VigiLanz’s clinical surveillance data.

Watch below to learn more from Houston Methodist’s System Director of Clinical Pharmacy Services, Michael Liebl, PharmD, BCPS.

 

Real-time Antimicrobial Stewardship Improves Care at Intermountain Healthcare

Laurie Blankenship, PharmD, Pharmacy Director at Park City Hospital of Intermountain Healthcare, discusses the benefits of working with VigiLanz on a daily basis.

“I can remember five years ago, when we didn’t have VigiLanz or any kind of software for antimicrobial stewardship, and we didn’t have nearly as many good catches and we didn’t make nearly as many interventions,” says Blankenship.

Watch this short video to learn more about how Blankenship and her team are using VigiLanz to improve patient care.

 

Transcript:

I am the pharmacy director at Park City Hospital, which is one of the 23 hospitals at Intermountain Healthcare. It’s a community hospital, so it’s a little bit smaller. We only have 37 beds. Because of the size, I’m more of a working director. So I do a lot of clinical work. I do work with VigiLanz on a daily basis. I’m the co-chair of the Antimicrobial Stewardship Committee that we have at Park City Hospital.


I can remember five years ago when we didn’t have VigiLanz or any kind of software for antimicrobial stewardship and we didn’t have nearly as many good catches and we didn’t make nearly as many interventions.


VigiLanz helps keep us up to date on any cultures or results. So it’s the real time feature—so important because it gives us all that feedback right when it’s currently happening. Instead of looking through the medical chart and trying to find those blood cultures or the urine cultures, VigiLanz gives us that real time data. So it allows us to make more appropriate antibiotic choices, shortened duration of therapy, identify if there’s a bug drug mismatch and even identify discharged patients, which is a really big thing that we use it for. If the patient went home and their culture grew something that we need to change therapy, it’s a great tool for identifying those patients that are already out of our system.


My favorite part of working with VigiLanz is that we have all the information in one portal for antimicrobial stewardship. It includes our emergency room, it includes our ICU, it includes our med-surg, and all of it, again, is in real time. We have all that at our fingertips and an easily accessible tool to help us make the best decisions and to help us tailor and recommend, make awesome recommendations to physicians and to improve patient care. That’s the most important thing.

The Sharp Experience: Measuring the ROI of Clinical Surveillance | ASHP 2019

A technology’s return on investment can be measured in many ways. One of the key ROI measures at Sharp HealthCare—a San Diego-based health system made up of four acute-care hospitals, three specialty hospitals, and various medical groups and other facilities—is how well the technology supports its “Pillars of Excellence.”

Each day, Sharp HealthCare strives to achieve excellence in its seven Pillars of Excellence: Quality, Safety, Service, People, Finance, Growth and Community. And, the health system is finding that VigiLanz’s clinical surveillance platform is helping it achieve that goal.

Specifically, VigiLanz has created innovation and spurred improvements in safety, quality, finance, and people, says Mike Kruse, PharmD, MBA, BCPS, Manager of Pharmacy Clinical Services at Sharp HealthCare. At ASHP Midyear 2019, Kruse shared more about how VigiLanz is impacting the health system.